2021
DOI: 10.3389/fmed.2021.638097
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Significance of Plasma D-Dimer in COVID-19 Mortality

Abstract: It is not clear whether D-dimer can be an independent predictor of coronavirus disease 2019 (COVID-19) mortality, and the cut-off of D-dimer for clinical use remains to be determined. Therefore, a comprehensive analysis is still necessary to illuminate the clinical significance of plasma D-dimer in COVID-19 mortality. We searched PubMed, Embase, Cochrane Library, and Scopus databases until November 2020. STATA software was used for all the statistical analyses. The identifier of systematic review registration … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
21
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 25 publications
(30 citation statements)
references
References 95 publications
0
21
0
Order By: Relevance
“…The novel coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has become a major public health problem worldwide, leading to 5,551,314 deaths as of January 2022 [ 1 ]. Some major risk factors for developing severe COVID-19 include advanced age, increased body mass index (BMI), type 2 diabetes (T2D), and hypertension, among others [ 2 ]. Additionally, it has been reported that among individuals with worse COVID-19 outcomes, inefficient immune responses promote hyperinflammation, leading to a cytokine storm [ 3 , 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…The novel coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has become a major public health problem worldwide, leading to 5,551,314 deaths as of January 2022 [ 1 ]. Some major risk factors for developing severe COVID-19 include advanced age, increased body mass index (BMI), type 2 diabetes (T2D), and hypertension, among others [ 2 ]. Additionally, it has been reported that among individuals with worse COVID-19 outcomes, inefficient immune responses promote hyperinflammation, leading to a cytokine storm [ 3 , 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…Hyperinflammation and hypoxia-induced injury caused by SARS-CoV-2 infection induced endothelial cell dysfunction and increased thrombosis and d -dimer [ 13 ]. Previous studies showed that d -dimer levels were associated with severity and outcomes in COVID-19 patients [ 5 , 11 , 14 , 15 , 16 ]. Zheng et al reported that thrombocytopenia, neutrophilia, and lymphocytopenia were independent biomarkers associated with outcomes in COVID-19 patients in a retrospective study, as shown in the present study [ 51 ].…”
Section: Discussionmentioning
confidence: 99%
“…An excessive immune response against SARS-CoV-2 induced by inflammatory cytokines and chemokines (i.e., cytokine storm) can contribute to the development of critical respiratory failure due to ALI/ARDS [ 6 ]. Previous studies have shown that serum levels of certain biomarkers were associated with disease severity and outcomes [ 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 ]. Moreover, studies using prediction models (ISARIC4C and COVID-GRAM) reported that the areas under the curve (AUC) for predicting the outcome of COVID-19 patients, including mortality and/or ICU admission, were 0.774 and 0.706, respectively [ 17 , 18 ].…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, vaccination status could not interfere with our results. Some studies and reviews analyzed the predictive value of only one or two parameters, and their usefulness in predicting outcomes of COVID-19, e.g., the role of platelet/lymphocyte ratio [28], HbA 1c [29], vitamin D3 levels [30], obesity [31], d-dimer [32], lymphocyte, or neutrophil count [33]. Other studies tried to provide predictors from a more complete set of clinical markers.…”
Section: Discussionmentioning
confidence: 99%